Duopharma Biotech Bhd (7148) — Working Capital to Net Assets Ratio
Duopharma Biotech Bhd (7148) has a Working Capital to Net Assets ratio of 67.4% as of March 2026. Working capital of RM510.30 Million (current assets of RM824.80 Million minus current liabilities of RM314.50 Million) is measured against net assets of RM757.35 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Duopharma Biotech Bhd (7148) flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Duopharma Biotech Bhd Working Capital to Net Assets (2006–2025)
This chart shows how Duopharma Biotech Bhd's Working Capital to Net Assets ratio has evolved across 20 annual periods from 2006 to 2025. As of March 2026, the ratio stands at 67.4%, reflecting working capital of RM510.30 Million against net assets of RM757.35 Million MYR. See operational self-sufficiency of Duopharma Biotech Bhd to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Duopharma Biotech Bhd (2006–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Duopharma Biotech Bhd from 2006 to 2025, covering 20 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Duopharma Biotech Bhd (7148) market capitalisation.
| Year | WC/NA Ratio | Working Capital (MYR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 66.7% | RM505.45 Million | RM757.62 Million | RM819.41 Million | RM313.96 Million | ▼ -10.8 pp |
| 2024 | 77.5% | RM549.62 Million | RM709.15 Million | RM727.05 Million | RM177.43 Million | ▲ +3.2 pp |
| 2023 | 74.3% | RM510.34 Million | RM687.12 Million | RM677.07 Million | RM166.73 Million | ▲ +32.0 pp |
| 2022 | 42.3% | RM276.90 Million | RM655.22 Million | RM541.49 Million | RM264.59 Million | ▼ -0.1 pp |
| 2021 | 42.4% | RM264.49 Million | RM624.00 Million | RM494.80 Million | RM230.31 Million | ▼ -5.7 pp |
| 2020 | 48.1% | RM309.37 Million | RM643.82 Million | RM459.69 Million | RM150.32 Million | ▲ +14.5 pp |
| 2019 | 33.6% | RM177.76 Million | RM529.75 Million | RM417.20 Million | RM239.44 Million | ▲ +3.4 pp |
| 2018 | 30.1% | RM144.88 Million | RM481.04 Million | RM367.33 Million | RM222.44 Million | ▼ -18.8 pp |
| 2017 | 49.0% | RM234.96 Million | RM479.87 Million | RM356.62 Million | RM121.66 Million | ▼ -8.9 pp |
| 2016 | 57.9% | RM263.03 Million | RM454.52 Million | RM366.18 Million | RM103.16 Million | ▼ -4.3 pp |
| 2015 | 62.2% | RM279.63 Million | RM449.72 Million | RM354.35 Million | RM74.71 Million | ▲ +19.1 pp |
| 2014 | 43.1% | RM83.51 Million | RM193.63 Million | RM106.85 Million | RM23.35 Million | ▲ +1.7 pp |
| 2013 | 41.4% | RM75.63 Million | RM182.65 Million | RM94.19 Million | RM18.55 Million | ▼ -0.1 pp |
| 2012 | 41.5% | RM70.75 Million | RM170.50 Million | RM92.62 Million | RM21.87 Million | ▼ -1.3 pp |
| 2011 | 42.8% | RM70.41 Million | RM164.44 Million | RM95.82 Million | RM25.41 Million | ▼ -2.7 pp |
| 2010 | 45.5% | RM71.86 Million | RM157.87 Million | RM96.23 Million | RM24.37 Million | ▼ -11.6 pp |
| 2009 | 57.1% | RM81.54 Million | RM142.74 Million | RM98.52 Million | RM16.98 Million | ▼ -3.4 pp |
| 2008 | 60.5% | RM78.97 Million | RM130.55 Million | RM95.01 Million | RM16.04 Million | ▲ +9.4 pp |
| 2007 | 51.1% | RM58.38 Million | RM114.21 Million | RM67.76 Million | RM9.38 Million | ▼ -12.5 pp |
| 2006 | 63.6% | RM92.53 Million | RM145.43 Million | RM103.27 Million | RM10.74 Million | — |